These are some of the main recommendations of the European Medical Research Councils (EMRC) White Paper, ‘Present Status and Future Strategy for Medical Research in Europe’ which was debated at a meeting on 30 January 2008 in Frankfurt (Germany) with the participation of the Heads of Medical Research Councils in Europe, Editors of Medical Journals, Presidents of Medical Learned Societies and Deans of Medical Faculties in Europe.
The audience acclaimed the White paper and made the following recommendations:
Increased funding must be by sustainable growth,
Collaboration on big programmes is essential,
Research areas should be determined by health priorities and not only science topics,
Collaboration on an improvement of peer review of grants is essential - and peer reviewers should be acknowledged and rewarded,
MD/PhD programmes are important and should be of high quality,
the best researchers - like the Nobel Laureates at The Lindau meeting - to participate in teaching,
Novel technologies and research infrastructures are important as well as incentive in terms of decent salaries to attract and retain young researchers
To make the White Paper recommendations come true European and global collaboration is needed.
The White Paper is the result of a comprehensive analysis of the current state of medical research within Europe together with an assessment of the new challenges facing Europe’s citizens, with changing patterns of disease, environmental issues as global warming, and changing demographic factors with an ageing population. The paper was launched at a meeting between Janez Potocnik, EU Commissioner for Science and Research, and Professor Liselotte Højgaard, Chair of the European Medical Research Councils in Brussels on 6 December 2007.
The White Paper key recommendations include:
Implementation of best practice for funding and performing medical research – with distribution of funding in competition based on excellence and evaluated by peer review
Strengthened collaboration and coordination of medical research in Europe through the EMRC and its membership organisations, via the European Commission, the European Research Council and the learned medical societies
Revision of EC directives related to medical research
Implementation of equal opportunities for all researchersA doubling of public funding of medical research in Europe within the next ten years – to a minimum of 0.25% of gross domestic product (GDP)
Notes for editor
With its emphasis on a multidisciplinary and pan-European approach, the Foundation provides the leadership necessary to open new frontiers in European science.
Its activities include providing science policy advice (Science Strategy); stimulating co-operation between researchers and organisations to explore new directions (Science Synergy); and the administration of externally funded programmes (Science Management). These take place in the following areas: Physical and engineering sciences; Medical sciences; Life, earth and environmental sciences; Humanities; Social sciences; Polar; Marine; Space; Radio astronomy frequencies; Nuclear physics.
Headquartered in Strasbourg with offices in Brussels and Ostend the ESF’s membership comprises 77 national funding agencies, research performing agencies and academies from 30 European nations.
The Foundation’s independence allows the ESF to objectively represent the priorities of all these members.What is EMRC?
Press contact:Sofia Valleley
Thomas Lau | alfa
Decision-making research in children: Rules of thumb are learned with time
19.10.2016 | Max-Planck-Institut für Bildungsforschung
Young people discover the "Learning Center"
20.09.2016 | Research Center Pharmaceutical Engineering GmbH
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Health and Medicine
06.12.2016 | Life Sciences
05.12.2016 | Power and Electrical Engineering